Page last updated: 2024-08-23

idazoxan and Diabetes Mellitus, Type 2

idazoxan has been researched along with Diabetes Mellitus, Type 2 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellahsene, T; Dive, G; Godfroid, JJ; Guardiola-Lemaitre, B; Ktorza, A; Lamouri, A; Le Bihan, G; Manechez, D; Penicaud, L; Pfeiffer, B; Renard, P; Rondu, F; Touboul, E; Wang, X	1
Dive, G; Godfroid, JJ; Guardiola-Lemaître, B; Huet, J; Ktorza, A; Lamouri, A; Le Bihan, G; Lidy, S; Manéchez, D; Pelé-Tounian, A; Pénicaud, L; Pfeiffer, B; Renard, P; Rondu, F; Touboul, E; Wang, X	1
Doxey, JC; Efendic, S; Ostenson, CG; Pigon, J	1

Trials

1 trial(s) available for idazoxan and Diabetes Mellitus, Type 2

Article	Year
Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes. The Journal of clinical endocrinology and metabolism, 1988, Volume: 67, Issue:5 Topics: Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dioxanes; Dioxins; Glucose; Humans; Idazoxan; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged	1988

Article

Year

Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes.

The Journal of clinical endocrinology and metabolism, 1988, Volume: 67, Issue:5

Topics: Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dioxanes; Dioxins; Glucose; Humans; Idazoxan; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged

1988

Other Studies

2 other study(ies) available for idazoxan and Diabetes Mellitus, Type 2

Article	Year
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines . Journal of medicinal chemistry, 1997, Nov-07, Volume: 40, Issue:23 Topics: Animals; Blood Glucose; Cattle; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Design; Glucose Tolerance Test; Homeostasis; Imidazoles; Male; Models, Molecular; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2	1997
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines an Journal of medicinal chemistry, 1999, May-06, Volume: 42, Issue:9 Topics: Animals; Blood Glucose; Cattle; Cerebral Cortex; Diabetes Mellitus, Type 2; Drug Design; Drug Evaluation, Preclinical; Glucose Tolerance Test; Homeostasis; Hypoglycemic Agents; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Injections, Intraperitoneal; Insulin; Insulin Secretion; Kidney Cortex; Male; Piperazines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Drug; Structure-Activity Relationship	1999

Article

Year

Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines .

Journal of medicinal chemistry, 1997, Nov-07, Volume: 40, Issue:23

Topics: Animals; Blood Glucose; Cattle; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Design; Glucose Tolerance Test; Homeostasis; Imidazoles; Male; Models, Molecular; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2

1997

Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines an

Journal of medicinal chemistry, 1999, May-06, Volume: 42, Issue:9

Topics: Animals; Blood Glucose; Cattle; Cerebral Cortex; Diabetes Mellitus, Type 2; Drug Design; Drug Evaluation, Preclinical; Glucose Tolerance Test; Homeostasis; Hypoglycemic Agents; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Injections, Intraperitoneal; Insulin; Insulin Secretion; Kidney Cortex; Male; Piperazines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Drug; Structure-Activity Relationship

1999